Keywords: clinical pharmacy, chronical pancreatitis, comorbidity, drugs, pharmacotherapy


The article presents the results of the research concerning the pharmacotherapy of patients with chronic pancreatitis with comorbidity from the pharmacological view. During the study pharmacological approach to the problem of comorbidity among patients with chronic pancreatitis was analyzed. A survey among doctors and pharmacists was used during the research along with normative and legal, documentary, retrospective, bibliographic, systemic, forensic-pharmaceutical, sociological (questionnaire survey), comparative, graphic, mathematical analysis methods. The most common comorbid diseases that patients suffer from alongside with chronic pancreatitis were highlighted. Authors came to conclusion, that development of safe and affordable pharmaceutical therapy for patients with chronic pancreatitis and comorbidity is very important.


Boyd C.M., Darer J., Boult C. et al. (2005) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA, 294(6): 716–724.

Dawes M. (2010) Co-morbidity: we need a guideline for each patient not a guideline for each disease. Fam. Pract., 27(1): 1–2.

Fortin M., Bravo G., Hudon C. et al. (2005) Prevalence of multimorbidity among adults seen in family practice. Ann. Fam. Med., 3(3): 223–228.

Comorbidity: [Electronic resource]. Acess mode:

Belousov Yu. V. (2012) Comorbidity in diseases of the digestive system. Zdorovya rebenka, 1 (36): 134–136.

Campbell-Scherer D. (2010) Multimorbidity: a challenge for evidence-based medicine. Evid. Based Med., 15(6): 165–166.

Ministry of healthcare of Ukraine official site [Electronic resource]. URL: (application date 07.05.2018). Title from the screen.

Caughey G.E., Vitry A.I., Gilbert A.L., Roughead E.E. (2008) Prevalence of comorbidity of chronic diseases in Australia. BMC Public Health, 8: 221.

Löhr J. M. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis // United European Gastroenterology Journal. 2017. Vol. 5, Issue 2. P. 153–199. doi:

Experience of Great Britain in organization of healthcare system for pharmaceutical provision with medicines for privileged categories of citizens / V.V. Shapovalov (Jr.), V.O. Shapovalova, V.V. Andrieieva, V.V. Shapovalov. Health of society. 2019. Vol. 78, N. 1. P. 36–40. (doi: 10.22141/2306-2436.8. 1.2019.172617).

Experience of Poland concerning and organization of healthcare system for the pharmaceutical provision for privileged categories of citizens / V.V. Shapovalov (Jr.), A.O. Gudzenko, V.A. Shapovalova, V.V. Andrieieva, V.V. Shapovalov. Proceeding of articles the international scientific conference «Advance of Science». Czech Republic, Karlovy Vary – Ukraine, Kyiv, 17 May 2019. Czech Republic, Karlovy Vary: Skleněný Můstek – Ukraine, Kyiv: MCNIP, 2019. P. 16-22.

Experience of the USA concerning and organization of healthcare system for the pharmaceutical provision for privileged categories of citizens / V.V. Shapovalov (Jr.), A.A. Gudzenko, V.V. Andrieieva, V.А. Shapovalova, V.V. Shapovalov Annals of Mechnikov Institute. 2019. N. 1. Р. 81–87. (doi: 10.5281/zenodo.2639521).

Freeman J. S. Providing whole-person care: integrating behavioral health into primary care. N.C. Med. J. 2015. Vol. 76, N 1. P. 24–25, 27–28.

Concerning the importance of forensic and pharmaceutical researches to improve patients’ accessibility to medicines / V. Shapovalov, А. Gudzenko, L. Komar, А. Butko, V. Shapovalova, V.Shapovalov. Pharmacia. 2017. Vol. 65. N. 2. P. 23–29.

Forensic and pharmaceutical study of the presence of a causal link between the degree of alcohol abuse and qualification level of the respondents / V. Shapovalov, A. Gudzenko, V. Shapovalova, A. Osyntseva, V. Shapovalov. Pharmacia. 2017. Vol. 66, N. 3. Р. 31–39.

Organizational and legal evaluation of availability of medicines’ circulation for cancer patients / V.V. Shapovalov, S.I. Zbrozhek, V.O. Shapovalova, V.V. Shapovalov. Pharmacia. 2018. Vol. 65, N. 2. P. 17-22.

Chernobrovkina T.V., Artemchuk A.F. The problem of comorbidity and modern forms of alcoholic disease (clinical and pathogenetic aspect). Narcology, 12/2006, 47-74 pp.

Carvalho A.K., Menezes A.M., Camelier A. et al. (2012) Prevalence of self-reported chronic diseases in individuals over the age of 40 in São Paulo, Brazil: the PLATINO study. Cad. Saude Publica, 28(5): 905–912.

Caughey G.E., Roughead E.E. (2011) Multimorbidity research challenges: where to go from here? Journal of Comorbidity, 1: 8–10.

Coebergh J.W., Janssen-Heijnen M.L., Post P.N., Razenberg P.P. (1999) Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993–1996. J. Clin. Epidemiol., 52(12): 1131–1136.

Caughey G.E., Ramsay E.N., Vitry A.I. et al. (2010) Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study. J. Epidemiol. Community Health, 64(12): 1036–1042.

Health insurance and mortality in US adults / A. P. Wilper, S. Woolhandler, K. E. Lasser, D. McCormick, D. H. Bor. American Journal of Public Health. 2009. Vol. 99. N. 12. Р. 2289-2295.

WHO Drug Information. [Electronic resource]. URL: (application date 07.05.2018). Title from the screen.

Study of Medication Errors on a Community Hospital Oncology Ward. 2016. [Electronic resource]. PubMed. URL: (application date 07.05.2018). Title from the screen.

Heilmann P. To have and to hold: personnel shortage in a Finnish healthcare organisation. Scand. J. Public. Health. 2010. Vol. 38. N. 5. Р. 518-523.

Meta D., Shukhov V., Chuchalin A. The British national form (politics, structure, features, example for imitation). [Electronic resource]. URL: (application date 24.07.2017). Title from the screen.





How to Cite
Iryna Tukhar, Viktoriya Shapovalova, Valentyn Shapovalov, & Valeriy Shapovalov. (2021). PHARMACOLOGICAL VIEW ON THE PROBLEM OF COMORBIDITY IN THE PHARMACOTHERAPY OF CHRONIC PANCREATITIS. Science Review, (3(38).